Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|12|1|22-31

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.12, Iss.1, 2015-01, pp. : 22-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synaptic Fatigue is More Pronounced in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 137-140

Bentham Science Publishers

Access to resources Recommend Favorite

Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer’s Disease After Implantation of VEGF-loaded PLGA Nanospheres

By  

Current Alzheimer Research, Vol. 12, Iss. 10, 2015-12 ,pp. : 932-9

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and permeability changes of the blood-brain barrier in APP/PS1 mice: an Alzheimer's disease animal model

By Wang Yulin   Liu Jing   Zhang Zhongmin   Wang Xiaoli   Zhang Chaodong  

Neurochemical Journal, Vol. 5, Iss. 3, 2011-09 ,pp. : 220-222

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Valproic Acid Attenuates Neuronal Loss in the Brain of APP/PS1 Double Transgenic Alzheimer's Disease Mice Model

By  

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 261-269

Bentham Science Publishers

Access to resources Recommend Favorite

Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease

By Schäfer S.   Wirths O.   Multhaup G.   Bayer T. A.  

Journal of Neural Transmission, Vol. 114, Iss. 3, 2007-03 ,pp. : 387-394

Springer Publishing Company

Access to resources Recommend Favorite